Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)

Previous studies among patients with atrial fibrillation showed that a history of heart failure (HF) could negatively impact anticoagulation quality, as measured by the average time in therapeutic range (TTR). Whether additional markers of HF severity are associated with TTR has not been investigate...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Am J Cardiol
Главные авторы: Lee, Tetz C., Qian, Min, Lip, Gregory Y.H., Di Tullio, Marco R., Graham, Susan, Mann, Douglas L., Nakanishi, Koki, Teerlink, John R., Freudenberger, Ronald S., Sacco, Ralph L., Mohr, J.P., Labovitz, Arthur J., Ponikowski, Piotr, Lok, Dirk J., Estol, Conrado, Anker, Stefan D., Pullicino, Patrick M, Buchsbaum, Richard, Levin, Bruce, Thompson, John L.P., Homma, Shunichi, Ye, Siqin
Формат: Artigo
Язык:Inglês
Опубликовано: 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6151139/
https://ncbi.nlm.nih.gov/pubmed/30037426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2018.05.024
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы